Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
06/2007
06/14/2007CA2631037A1 Bradykinin 1 receptor antagonists
06/13/2007CN1980923A Polycyclic pyridines as potassium ion channel modulators
06/13/2007CN1980889A Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/07/2007WO2007064861A2 Asymmetric friedel-crafts alkylations catalyzed by byfunctional cinchona alkaloids
06/07/2007WO2007043653A9 Benzimidazole-5-carboxamide derivative
06/07/2007US20070129398 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis
06/06/2007CN1976706A Inhibition of FGFR3 and treatment of multiple myeloma
06/06/2007CN1976701A 毒蕈碱性乙酰胆碱受体拮抗剂 Muscarinic acetylcholine receptor antagonist
06/06/2007CN1319967C 2-acylaminothiazole derivative or salt thereof
06/05/2007US7226918 DNA-PK inhibitors
05/2007
05/31/2007WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof
05/31/2007US20070123525 5-Substituted indole-2-carboxamide derivatives
05/31/2007US20070123475 podophyllotoxin analogs such as 4-beta-[(4''-benzamido)-amino]-4'-demethyl-epipodophyllotoxins and their 4'-ester derivatives used in the chemotherapy for various types of cancer
05/31/2007US20070122444 Medical devices employing triazine compounds and compositions thereof
05/30/2007EP1790643A1 Quinuclidine compounds having quaternary ammonium group, it's preparation method and use as blocking agents of acetycholine
05/30/2007CN1318031C Compositions containing benzoxazinone and nucleoside like materials
05/24/2007WO2007028073A3 Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
05/24/2007WO2007018738A8 Fused bicycloheterocycle substituted quinuclidine derivatives
05/24/2007US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders
05/24/2007US20070117796 Carbamate compounds as 5-HT4 receptor agonists
05/24/2007US20070117795 Methods and compositions of novel triazine compounds
05/23/2007EP1786810A1 Ligands for g-protein coupled receptors
05/23/2007EP1786809A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
05/23/2007CN1968951A Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-l-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor
05/22/2007US7220856 Substituted quinoline CCR5 receptor antagonists
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007CA2157579C Heterocyclic compounds, their use and preparation
05/17/2007US20070112199 Asymmetric aldol additions using bifunctional cinchona-alkaloid-based catalysts
05/17/2007US20070112023 (3R)-N-(4'-Aminobiphenyl-4-yl)quinuclidine-3-carboxamide dihydrochloride; nicotinic acetylcholine receptors of alpha7 subtype agonist; high permeability for calcium ions, increases glutamatergic neurotransmission, modulates neuronal plasticity; cognition activator, leaning and perception inhancement
05/17/2007US20070111991 10,11-Dihydro-dibenzo[b,f]oxepine-10-carboxylic acid [(1S*,2S*,4R*)-4-butylcarbamoyl-2-hydroxy-1-(3-hydroxy-benzyl)-pentyl]-amide; treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation
05/10/2007WO2007051496A1 Process for the preparation of n-triazinylammonium salts
05/10/2007US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same
05/10/2007US20070105896 3-Imidazol-1-yl-1-azabicyclo[2.2.2]octane; agonist, partial agonist, or antagonist of the alpha 7 nicotinic acetylcholine receptor; antidepressant, anxiolytic agent, cognition activator, neuroprotectant; radiolabel
05/09/2007EP1781651A1 Process for preparing quinuclidinium carbamate derivatives
05/09/2007EP1781290A2 Anti-inflammatory agents
05/08/2007US7214692 Medical use for tachykinin antagonists
05/08/2007US7214688 Compounds
05/08/2007US7214687 Quinuclidine derivatives and medicinal compositions containing the same
05/08/2007US7214686 adjust release of neurotransmitters; Parkinson's disease; tourette Syndrome; attention deficit disorders; schizophrenia
05/03/2007WO2006130437A3 Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
05/03/2007US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis
05/03/2007US20070099874 Methods and compositions of novel triazine compounds
05/02/2007EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
05/02/2007CN1956964A Tetrahydro-indazole cannabinoid modulators
05/02/2007CN1956943A Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides
04/2007
04/26/2007WO2007045478A1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders
04/26/2007WO2007045151A1 Compounds and their pharmaceutical compositions for the treatment of nasal cavum hypersecretion and chronic obstructive pulmonary disease
04/26/2007CA2622356A1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders
04/25/2007EP1776360A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases.
04/25/2007EP1487834B1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
04/25/2007CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
04/24/2007US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders
04/19/2007WO2007043653A1 Benzimidazole-5-carboxamide derivative
04/19/2007US20070088054 Biphenyl derivatives
04/18/2007EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators
04/18/2007CN1310914C Acid absorbing agent for preparing cinchona alkaloids ligand
04/18/2007CN1310913C Recoverable repeatable use chirality cinchona alkaloid ligand and application
04/17/2007US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders
04/17/2007CA2202775C Method for treating anxiety
04/12/2007US20070083049 Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
04/11/2007CN1946712A Pyrrolidine derivative
04/11/2007CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins
04/05/2007WO2007038367A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
04/05/2007US20070078265 Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
04/05/2007CA2622677A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
04/04/2007CN1939307A 2,4,6-triamino-1,3,5-triazine derivative
03/2007
03/29/2007WO2007018738A3 Fused bicycloheterocycle substituted quinuclidine derivatives
03/29/2007WO2006108965A3 Npy antagonists, preparation and use
03/29/2007US20070072887 Spirofuropyridine aryl derivatives
03/29/2007US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/28/2007EP1256581B1 Preventive or therapeutic agents for gastric or esophageal regurgitation
03/28/2007CN1938283A Pyridazinones as antagonists of alpha4 integrins
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196098 Quinuclidine derivatives and medicinal compositions containing the same
03/27/2007US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection
03/27/2007CA2180841C 1-aminoindan derivatives and compositions thereof
03/22/2007US20070066663 disorders of the central and/or peripheral nervous system; minimal interaction with metabolic enzymes, improved selectivity, potentiation, acid resistance, bioavailibility; (3S) N-(2-Methylpropyl)-N-{[2-(trifluoromethyl)-phenyl]methyl}piperidin-3-amine; depression, urinary incontinence; pain
03/22/2007US20070066592 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, senile dementia, AIDS dementia, Pick's Disease, dementia associated with Down's syndrome; alpha 7 nAChR ligands modulators
03/21/2007CN1934109A Composition for solid pharmaceutical preparation of solifenacin or salt thereof
03/21/2007CN1934090A Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
03/15/2007US20070060588 Fused bicycloheterocycle substituted quinuclidine derivatives
03/15/2007US20070060563 Quinuclidine derivatives binding to mucarinic m3 receptors
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1930158A New quaternized quinuclidine esters
03/14/2007CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
03/08/2007WO2007028073A2 Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
03/07/2007EP1758899A1 Asymmetric michael and aldol addition using bifunctional cinchona-alkaloid-based catalysts
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/06/2007US7186731 2-cyanopyrrolidinecarboxamide compound
03/06/2007CA2294990C Pharmaceutical compositions and methods for effecting dopamine release
02/2007
02/28/2007EP1757604A1 Process for producing solifenacin or its salt
02/28/2007EP1461335B1 2-heteroarylcarboxylic acid amides
02/28/2007CN1922176A Condensed bicycle heterocycle substituted quinuclidine derivant
02/28/2007CN1922172A Substituted heterocyclic compounds and uses thereof
02/27/2007US7183323 Sodium channel modulators
02/27/2007US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants
02/22/2007US20070043051 Methods and compositions of novel triazine compounds
02/22/2007US20070043017 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
02/21/2007EP1651645B1 N-biarylamides
02/21/2007CN1918157A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 58